z-logo
open-access-imgOpen Access
Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species
Author(s) -
Irwin J. Trestman,
Donald Kaye,
Matthew E. Levison
Publication year - 1979
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.16.3.283
Subject(s) - carbenicillin , mecillinam , ticarcillin , microbiology and biotechnology , piperacillin , ampicillin , bacteroides fragilis , mezlocillin , chemistry , agar dilution , antibiotics , biology , minimum inhibitory concentration , clavulanic acid , escherichia coli , enterobacteriaceae , bacteria , biochemistry , amoxicillin , pseudomonas aeruginosa , genetics , gene
The minimal inhibitory concentrations (MIC) of six penicillins (ampicillin, carbenicillin, ticarcillin, piperacillin, mezlocillin, and Bay k 4999) against 29 clinical isolates of Bacteriodes spp. (including Bacteroides fragilis, Bacteroides thetaiotaomicron, and Bacteroides vulgatus) were determined by an agar dilution method. Bay k 4999 was most active, followed in descending order by ampicillin, piperacillin, mezlocillin, ticarcillin, and carbenicillin. Mecillinam, a 6 beta-amidino-penicillanic acid, inhibited no strains at 50 micrograms/ml, but when compared with ampicillin, a fourfold or greater increase in MIC for ampicillin (antagonism) was noted in 3 of 29 strains, with no effect on MIC for 26 strains, whereas when combined with carbenicillin, a fourfold or greater decrease in MIC for both antibiotics (synergism) was noted in 12 strains, 4 of which had an MIC of greater than or equal to 250 micrograms/ml for carbenicillin alone. These studies demonstrate the increased activity of some newer semisynthetic penicillins and the potential synergy obtained with mecillinam and carbenicillin against Bacteroides sp.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here